Clinical trials
Recruiting Hematologic Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| Ottawa Hospital Research Institute | 2 |
| CSL Behring | 1 |
| Cogent Biosciences, Inc. | 1 |
| Kura Oncology, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| Swedish Orphan Biovitrum | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 9 |
| Leukemia | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Agammaglobulinemia | 1 |
| Arthritis, Psoriatic | 1 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
| Burkitt Lymphoma | 1 |
| Colitis, Ulcerative | 1 |
| Crohn Disease | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.